Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cabaletta Bio, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 61 | 72 | +11 |
| Shares | 19.9M | 24.6M | +4.76M (+24.0%) |
| Value | $183.9M | $203.9M | +$20.0M (+10.9%) |
New holders (23)
Institutions that held Cabaletta Bio, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jennison Associates LLC | 780,564 | $6.46M | 0.01% |
| Velan Capital Investment Management LP | 250,000 | $2.07M | 1.83% |
| Goldman Sachs Group Inc | 161,596 | $1.34M | 0.00% |
| HRT Financial LP | 100,224 | $828.0K | 0.01% |
| Squarepoint Ops LLC | 57,064 | $471.9K | 0.00% |
| Citigroup Inc | 45,752 | $378.4K | 0.00% |
| UBS Oconnor LLC | 45,000 | $372.1K | 0.01% |
| Cubist Systematic Strategies, LLC | 36,457 | $301.5K | 0.00% |
| First Republic Investment Management, Inc. | 33,065 | $273.4K | 0.00% |
| LPL Financial LLC | 24,780 | $204.9K | 0.00% |
| Envestnet Asset Management Inc | 20,893 | $172.8K | 0.00% |
| Concorde Asset Management, LLC | 15,800 | $130.7K | 0.15% |
| LMR Partners LLP | 13,422 | $111.0K | 0.00% |
| Diametric Capital, LP | 10,966 | $90.7K | 0.04% |
| Trexquant Investment LP | 10,511 | $86.9K | 0.00% |
| Point72 Asset Management, L.P. | 5,243 | $43.4K | 0.00% |
| Point72 Middle East FZE | 3,742 | $30.9K | 0.00% |
| Denali Advisors LLC | 1,400 | $11.6K | 0.00% |
| WR Wealth Planners, LLC | 900 | $7.44K | 0.00% |
| The PNC Financial Services Group, Inc. | 576 | $4.76K | 0.00% |
| Private Trust Co NA | 368 | $3.04K | 0.00% |
| Bogart Wealth, LLC | 50 | $414 | 0.00% |
| FMR LLC | 14 | $116 | 0.00% |
Sold out (12)
Institutions that held Cabaletta Bio, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Eversept Partners, LP | 282,874 | $2.62M |
| Boone Capital Management LLC | 266,882 | $2.47M |
| Kynam Capital Management, LP | 165,486 | $1.53M |
| Walleye Capital LLC | 60,505 | $559.7K |
| Ikarian Capital, LLC | 30,286 | $280.1K |
| Jefferies Financial Group Inc. | 25,000 | $231.3K |
| Crestline Management, LP | 22,107 | $204.5K |
| Marquette Asset Management, LLC | 13,539 | $125.2K |
| Freedom Wealth Alliance, LLC | 4,416 | $40.8K |
| Investors Research Corp | 150 | $1.39K |
| GWM Advisors LLC | 140 | $1.29K |
| FNY Investment Advisers, LLC | 200 | $1.00K |